Back to search

Article

Oral, but not rectal delivery of epigallocatechin-3-gallate alleviates colitis by regulating the gut microbiota, oxidative stress, inflammation, and barrier integrity

2020-08-06

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Alteration of the gut microbiota may contribute to the development of inflammatory bowel diseases (IBDs). Epigallocatechin-3-gallate (EGCG), a major bioactive constituent of green tea, is known to be beneficial in IBDs alleviation. However, it is unclear whether EGCG attenuates IBDs through direct improvement of gastrointestinal function or indirect alteration o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6aadfe39-03a0-5846-98d5-09303fec5e66
DOI
10.21203/rs.3.rs-52274/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Oral, but not rectal delivery of epigallocatechin-3-gallate alleviates colitis by regulating the gut microbiota, oxidative stress, inflammation, and barrier integrityDOI 10.21203/rs.3.rs-52274/v1
Select a neighboring publication to make it the new centre.